Follow
Claudio Hidalgo Cantabrana
Claudio Hidalgo Cantabrana
CEO at Microviable Therapeutics SL
Verified email at microviable.com
Title
Cited by
Cited by
Year
Bifidobacteria and their health‐promoting effects
C Hidalgo-Cantabrana, S Delgado, L Ruiz, P Ruas-Madiedo, B Sánchez, ...
Bugs as Drugs: Therapeutic Microbes for the Prevention and Treatment of …, 2018
3302018
Immune modulation capability of exopolysaccharides synthesised by lactic acid bacteria and bifidobacteria
C Hidalgo-Cantabrana, P López, M Gueimonde, ...
Probiotics and Antimicrobial Proteins 4, 227-237, 2012
2472012
Genomic overview and biological functions of exopolysaccharide biosynthesis in Bifidobacterium spp
C Hidalgo-Cantabrana, B Sánchez, C Milani, M Ventura, A Margolles, ...
Applied and Environmental Microbiology 80 (1), 9-18, 2014
2232014
Gut microbiota dysbiosis in a cohort of patients with psoriasis
C Hidalgo‐Cantabrana, J Gómez, S Delgado, S Requena‐López, ...
British Journal of Dermatology 181 (6), 1287-1295, 2019
1642019
Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus
C Hidalgo-Cantabrana, YJ Goh, M Pan, R Sanozky-Dawes, R Barrangou
Proceedings of the National Academy of Sciences 116 (32), 15774-15783, 2019
1472019
Chemical and biological properties of the novel exopolysaccharide produced by a probiotic strain of Bifidobacterium longum
R Inturri, A Molinaro, F Di Lorenzo, G Blandino, B Tomasello, ...
Carbohydrate Polymers 174, 1172-1180, 2017
1072017
Monitoring in real time the formation and removal of biofilms from clinical related pathogens using an impedance-based technology
D Gutiérrez, C Hidalgo-Cantabrana, A Rodríguez, P García, ...
PloS one 11 (10), e0163966, 2016
932016
Structure of the high molecular weight exopolysaccharide produced by Bifidobacterium animalis subsp. lactis IPLA-R1 and sequence analysis of its putative eps cluster
S Leivers, C Hidalgo-Cantabrana, G Robinson, A Margolles, ...
Carbohydrate research 346 (17), 2710-2717, 2011
892011
A single mutation in the gene responsible for the mucoid phenotype of Bifidobacterium animalis subsp. lactis confers surface and functional characteristics
C Hidalgo-Cantabrana, B Sánchez, P Álvarez-Martín, P López, ...
Applied and Environmental Microbiology 81 (23), 7960-7968, 2015
852015
CRISPR-based engineering of next-generation lactic acid bacteria
C Hidalgo-Cantabrana, S O’Flaherty, R Barrangou
Current opinion in microbiology 37, 79-87, 2017
842017
Exopolysaccharide-producing Bifidobacterium animalis subsp. lactis strains and their polymers elicit different responses on immune cells from blood and gut associated lymphoid …
C Hidalgo-Cantabrana, M Nikolic, P López, A Suárez, M Miljkovic, M Kojic, ...
Anaerobe 26, 24-30, 2014
802014
Characterization and exploitation of CRISPR loci in Bifidobacterium longum
C Hidalgo-Cantabrana, AB Crawley, B Sanchez, R Barrangou
Frontiers in Microbiology 8, 298934, 2017
732017
Comparative analysis of Lactobacillus gasseri and Lactobacillus crispatus isolated from human urogenital and gastrointestinal tracts
M Pan, C Hidalgo-Cantabrana, YJ Goh, R Sanozky-Dawes, R Barrangou
Frontiers in microbiology 10, 499288, 2020
582020
Characterization and repurposing of type I and type II CRISPR–Cas systems in bacteria
C Hidalgo-Cantabrana, YJ Goh, R Barrangou
Journal of molecular biology 431 (1), 21-33, 2019
552019
Effect of a Ropy Exopolysaccharide-Producing Bifidobacterium animalis subsp. lactis Strain Orally Administered on DSS-Induced Colitis Mice Model
C Hidalgo-Cantabrana, F Algieri, A Rodriguez-Nogales, T Vezza, ...
Frontiers in Microbiology 7, 868, 2016
512016
Effects of Xylitol on Xylitol-Sensitive Versus Xylitol-Resistant Streptococcus mutans Strains in a Three-Species in Vitro Biofilm
AM Marttinen, P Ruas-Madiedo, C Hidalgo-Cantabrana, MA Saari, ...
Current microbiology 65, 237-243, 2012
482012
Characterization and applications of Type I CRISPR-Cas systems
C Hidalgo-Cantabrana, R Barrangou
Biochemical Society Transactions 48 (1), 15-23, 2020
452020
Bifidobacteria and their health-promoting effects. Microbiol. Spectr. 2017; 5 doi: 10.1128/microbiolspec
C Hidalgo-Cantabrana, S Delgado, L Ruiz, P Ruas-Madiedo, B Sánchez, ...
BAD-0010-2016.[Abstract][CrossRef][Google Scholar], 2017
442017
Capability of exopolysaccharide-producing Lactobacillus paraplantarum BGCG11 and its non-producing isogenic strain NB1, to counteract the effect of enteropathogens upon the …
M Zivkovic, C Hidalgo-Cantabrana, M Kojic, M Gueimonde, N Golic, ...
Food Research International 74, 199-207, 2015
342015
Comprehensive Mining and Characterization of CRISPR-Cas Systems in Bifidobacterium
M Pan, MA Nethery, C Hidalgo-Cantabrana, R Barrangou
Microorganisms 8 (5), 720, 2020
322020
The system can't perform the operation now. Try again later.
Articles 1–20